These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 17722420)

  • 1. The use of biochemical markers of bone turnover in osteoporosis.
    Allende-Vigo MZ
    P R Health Sci J; 2007 Jun; 26(2):91-5. PubMed ID: 17722420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of serum and urine bone markers in the management of osteoporosis.
    Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
    Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical markers of bone metabolism: clinical value in general practice].
    Seibel MJ
    Ther Umsch; 1998 Nov; 55(11):676-84. PubMed ID: 9865144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of biochemical markers in the management of osteoporosis.
    Ebeling PR; Akesson K
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):385-400. PubMed ID: 11485336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical use of biological markers of bone turnover in osteoporosis].
    Bergmann P
    Rev Med Brux; 2008 Sep; 29(4):295-300. PubMed ID: 18949980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
    Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
    Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
    Woitge HW; Seibel MJ
    Clin Lab Med; 2000 Sep; 20(3):503-25, vi. PubMed ID: 10986618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of therapeutic intervention on bone mass and turnover through monitoring of biochemical markers of bone turnover].
    Ohta H
    Nihon Rinsho; 2006 Sep; 64(9):1663-9. PubMed ID: 16972676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers of bone remodeling in assessment of osteoporosis].
    Stĕpán J
    Cas Lek Cesk; 1997 Oct; 136(19):591-7. PubMed ID: 9600139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fracture risk and biochemical markers of bone turnover].
    Chaki O
    Clin Calcium; 2005 Aug; 15(8):1339-45. PubMed ID: 16062004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Place of biochemical markers of bone turnover in guidelines for diagnosis and treatment of osteoporosis].
    Kiryłów E; Kamiński G
    Pol Merkur Lekarski; 2008 Oct; 25(148):386-9. PubMed ID: 19145942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bone marker plot: an innovative method to assess bone turnover in women.
    Bieglmayer C; Kudlacek S
    Eur J Clin Invest; 2009 Mar; 39(3):230-8. PubMed ID: 19260953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of markers of bone degradation and formation.
    Demers LM
    Scand J Clin Lab Invest Suppl; 1997; 227():12-20. PubMed ID: 9127464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.